Fundraising FoxNome
3 known investors
Find your way into Nome
Sign up to see every warm intro you have to Nome
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nome team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nome offers genetic medicine development as a service, helping rare disease families, foundations, and health systems access and develop personalized n-of-1 genetic therapies. It combines an AI platform with human experts to guide therapeutic programs from treatment design through clinical execution.
Founders & leadership
SR
Stevie RingelFounder
Investors · 3
Ankur CapitalreportedMumbai · $500K – $2M
How we know: economictimes.indiatimes.com · funding news · Not right? Tell us
Also in the syndicate · 1
Campus Fund
Funding
SEC filings, press & company announcements- Undisclosed amountseedJan 2023
Ankur Capital, Campus Fund
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Nome do?
- Nome offers genetic medicine development as a service, helping rare disease families, foundations, and health systems access and develop personalized n-of-1 genetic therapies. It combines an AI platform with human experts to guide therapeutic programs from treatment design through clinical execution.
- Who founded Nome?
- Nome was founded by Stevie Ringel.
- Who are Nome's investors?
- Nome's investors include Twelve Below, Ankur Capital.